Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
A phase 3 trial of Cyclophosphamide, Docetaxel, Epirubicin, Fluorouracil and Ixabepilone in Breast cancer, run by UNICANCER, completed.
Overview
Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer is a phase 3 interventional study registered as NCT00630032 by UNICANCER, with 762 participants recorded, started 2007-09 and reaching its primary completion in 2017-06. Interventions recorded: cyclophosphamide, Docetaxel, epirubicin hydrochloride, fluorouracil, ixabepilone. Conditions recorded: Breast Cancer.
Linked to the drug Ixabepilone because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialSequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Shares Epirubicin, Fluorouracil (5-FU), Docetaxel, Breast cancer (all types) and the tag pipeline.
- TrialRandomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
Shares Epirubicin, Fluorouracil (5-FU), Docetaxel, Breast cancer (all types) and the tag pipeline.
- TrialSix vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
Shares Epirubicin, Fluorouracil (5-FU), Docetaxel, Breast cancer (all types) and the tag pipeline.
- TrialCalcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
Shares Ixabepilone, Breast cancer (all types) and the tag pipeline.
- TrialChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Shares Docetaxel, Breast cancer (all types), Cyclophosphamide and the tag pipeline.
- TrialPrecise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids
Shares Epirubicin, Docetaxel and the tag pipeline.
- TrialA Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
Shares Ixabepilone and the tag pipeline.
- TrialA Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
Shares Epirubicin, Cyclophosphamide and the tag pipeline.